Health Ministry: No shortage of HCQ tablets in country

New Delhi: The health minitry has ensured that there is no shortage of hydroxychloroquine tablets (HCQ) in the country at present as well as in the future, accordinh to Union Health Ministry Joint Secretary Lav Aggarwal.

“It is ensured that not only today even in future there will not be any lack of HCQ (hydroxychloroquine) as and when needed,” Aggarwal said.

Earlier, Temporary licensed was granted by the India for the export of paracetamol and anti-malarial drug hydroxychloroquine (HCQ) in appropriate quantities to some countries, which have been badly affected by the coronavirus pandemic.

According to the Indian Council of Medical Research (ICMR), “hydroxychloroquine is recommended only to those asymptomatic healthcare workers involved in the care of suspected or confirmed cases of COVID-19 and asymptomatic household contacts of laboratory-confirmed cases.”

“5,194 positive confirmed cases have been reported and 402 people have been discharged so far. Over the last 24 hours, 773 positive cases have been reported. A total of 149 deaths have been reported. As many as 32 people died yesterday,” Agarwal said.

  • Related Posts

    Lupin Ramps Up Strategy to Counter U.S. Tariff Threat, Posts 52% Profit Surge

    Mumbai, August 7, 2025 — Indian pharmaceutical giant Lupin is drawing up a multi-pronged strategy to navigate the looming threat of U.S. tariffs, while celebrating a robust 52% year-on-year surge…

    Fortis Q1 Profit Jumps 57%; Expansion Drives Growth

      Gurugram, August 7 – http://Fortis HealthcareFortis Healthcare has reported a 57% year-on-year increase in its net profit for the first quarter of FY2025. The hospital chain posted ₹260 crore…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Piyush Goyal meets pharma industry leaders to discuss R&D, competitiveness boost

    Piyush Goyal meets pharma industry leaders to discuss R&D, competitiveness boost

    Senores Pharma to Buy Two Teva ANDAs

    Senores Pharma to Buy Two Teva ANDAs

    Lab-grown rabies antibodies show promise as cheaper, safer alternative

    Lab-grown rabies antibodies show promise as cheaper, safer alternative

    Lilly launches Mounjaro KwikPen in India

    Lilly launches Mounjaro KwikPen in India